Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
Aortic StenosisRétrécissement de la valve aortique, un traitement par ultrasons Jul 20, 2022 READ MORE
Aortic StenosisSténose aortique : la technologie à ultrasons qui pourrait changer la donne Jun 22, 2022 READ MORE
Press ReleaseCardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis. Jun 14, 2022 READ MORE
Press ReleaseCardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France. May 2, 2022 READ MORE
Press ReleaseCardiawave announces the success of its clinical trial to treat aortic stenosis. Mar 22, 2022 READ MORE
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
